Method for the treatment of endotoxic shock in mammels

Details Method for the treatment of endotoxic shock in mammels Method for the treatment of endotoxic shock in mammels

A - Human Necessities

61

K

A61K 38/22 (2006.01)

Patent

CA 2294980

Disclosed is the use of vasoactive intestinal peptide (VIP) and the peptide activator of the hypophyseal adenylcyclase (PACAP) in the treatment of the endotoxic shock in mammals. These substances inhibit the production of the tumoral necrosis factor (TNF) and of interleukine 6 (IL-6).

L'invention concerne l'utilisation du peptide intestinal vasoactif (VIP) et du peptide activateur de l'adénylcyclase hypophysaire (PACAP) dans le traitement du choc endotoxique chez les mammifères. Ces substances inhibent la production du facteur de nécrose tumorale (TNF) et de l'interleukine 6 (IL-6).

Affiliated with

Also associated with

Rating

Method for the treatment of endotoxic shock in mammels does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the treatment of endotoxic shock in mammels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of endotoxic shock in mammels will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1631620